Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Rheonics wins award for Flexodruck sensors
Winterthur - Rheonics has won the FTA Technical Innovation Award 2021. With this, the American Flexographic Technical Association (FTA) commended the density and viscosity sensor specialist’s control system to measure ink viscosity in package printing.
Contovista supports artificial intelligence center
Schlieren ZH - Contovista is supporting the Swiss Federal Institute of Technology in Zurich with development of its artificial intelligence center. The FinTech company is bringing its experience in the finance industry to this project.
Cancer cells eliminate themselves
Zurich – Researchers at the University of Zurich have found a way for a tumor to produce therapeutic agents that make it eliminate itself. A virus is modified to act like a Trojan horse and deliver genes for cancer therapeutics directly into the tumor cell, passing the immune system undetected.
Investors accelerate expansion of nexoya
Zurich – New funds will help nexoya expand. The startup has received an investment totaling 1.4 million Swiss francs for its artificial intelligence-based solution for digital marketing campaigns. This will enable nexoya to launch in Germany this summer, before branching out to other European countries.
Antibody effective against mutations
Schlieren ZH - The MTX-COVAB antibody developed by Memo Therapeutics is effective against the original variant of the Sars-CoV-2 virus that causes coronavirus infections as well as the mutations that were first identified in the UK and South Africa. It is now being transferred to the clinical development phase.
Yova raises 11 million Swiss francs
Zurich - Yova has received a fresh capital injection totaling 11 million Swiss francs. The investors participating in the financing round are convinced that the start-up has really captured the Zeitgeist with its portal for sustainable investment. The investment will support expansion plans to further countries.
Building with repurposed material
Building with repurposed materials: At the NEST research and innovation building in the Greater Zurich Area, a model project is underway on this with business and research partners. An entire ecosystem is working on sustainable solutions to raise the material treasure of buildings with added value.
Researchers able to curb coronavirus growth
Zurich – An international team led by ETH Zurich has successfully generated molecule-precise insights into the replication mechanism of the coronavirus and how to inhibit this. The results could boost the development of drugs to combat the SARS-Cov-2 virus.
BC Platform cooperate with Artisan
Zurich - BC Platforms and Artisan Biomed have agreed a partnership. After securing access to the BC Platforms healthcare technology in the field of genetics, Artisan is now planning to drive forward the development of precision medicine in South Africa.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space